Clinical trials: Ovarian Hyper Stimulation Syndrome (OHSS)
Ovarian Hyper Stimulation Syndrome (OHSS)
Ovarian Hyperstimulation Syndrome Prevention
Ovarian hyperstimulation is a very hazardous complication of ICSI
- Trial name
- OHSS (NCT06739759)
- Testing
- Antagonist protocol for IVF, Modified Agonist protocol for IVF with additive treatments as HCQ
- Where
- 2 sites in Egypt
- Volunteers
- 300 people
- Sponsor
- Aljazeera Hospital
Ovarian Hyper Stimulation Syndrome (OHSS)
Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients
This study aims to evaluate whether the combination of Albumin and Furosemide can reduce the risk of Ovarian Hyperstimulation Syndrome in women undergoing intracytoplasmic sperm injection (ICSI) who are at high risk of developing…
- Trial name
- ALFURO-OHSS (NCT07568886)
- Testing
- Albumin (Human) 20%, Furosemide, Standard luteal phase support
- Where
- Iraq
- Volunteers
- 200 people
- Sponsor
- Al-Nahrain University
Ovarian Hyperstimulation Syndrome
The Influence of Timing of Cabergoline Initiation on Prevention of OHSS
Study the effect of early cabergoline administration in prevention of occurrence or decreasing the severity of OHSS in patients undergoing intra cytoplasmic sperm injection.And its effect on oocyte maturation,fertilization and…
- Trial name
- OHSS (NCT02620605)
- Testing
- Late Cabergoline 0.5mg, Early Cabergoline 0.5mg
- Where
- Egypt
- Volunteers
- 75 people
- Sponsor
- Mona M Shaban
Ovarian Hyperstimulation Syndrome (OHSS)
Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.
Ovarian hyper stimulation syndrome (OHSS) is a potentially serious complication of ovarian stimulation in IVF (In Vitro Fertilisation).
- Trial name
- SHOview (NCT01703728)
- Testing
- Highly purified menotropin (HP- hMG) treatment
- Where
- 20 sites in France
- Volunteers
- 455 people
- Sponsor
- Ferring Pharmaceuticals
Polycystic Ovarian Syndrome (PCOS), Patients Sensitive to Exogenous Gonadotropins
In Vitro Maturation (IVM) of Human Oocytes
We hypothesize that the combination of natural cycle IVF or low dose gonadotropin injection combined with In Vitro Maturation (IVM) (Natural IVF/IVM) is a viable option for a selected population of infertility patients who cannot…
- Conditions
- Polycystic Ovarian Syndrome (PCOS), Patients Sensitive to Exogenous Gonadotropins, Ovarian Hyper Stimulation Syndrome (OHSS)
- Trial name
- IVM (NCT01843569)
- Testing
- In Vitro maturation
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Northwell Health
Infertility
Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist
The purpose of this study is to see whether patients triggered with only human Chorion Gonadotropin (hCG) have higher number of Metaphase II oocytes (MII) and implantation rate than patients triggered with hCG combined with…
- Trial name
- NCT01607203
- Testing
- Decapeptyl Daily, pregnyl
- Where
- Belgium
- Volunteers
- 120 people
- Sponsor
- AZ Jan Palfijn Gent
Ovarian Hyperstimulation Syndrome
Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program
The purpose of this study is to investigate the efficacy and safety of cabergoline in prevention of ovarian hyperstimulation syndrome versus albumin in ART program.
- Trial name
- NCT01009567
- Testing
- Cabergoline, Control
- Where
- Iran
- Volunteers
- 10 people
- Sponsor
- Royan Institute
Ovarian Hyperstimulation Syndrome
Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome
This study is a prospective randomized clinical controlled trial to assess the efficacy of the Methylprednisolone for preventing ovarian hyper stimulation syndrome in in vitro fertilization (IVF) cycles.
- Trial name
- NCT01014104
- Testing
- Methylprednisolone, Control
- Where
- Iran
- Volunteers
- 218 people
- Sponsor
- Royan Institute
Ovarian Hyperstimulation Syndrome
Ovarian Hyperstimulation Syndrome Using Calcium Infusion
the incidence of OHSS and clinical outcomes after calcium IV infusion in high-risk women undergoing ART
- Trial name
- NCT05198128
- Testing
- Calcium intravenous infsuion, 0.9 % saline
- Volunteers
- 200 people
- Sponsor
- Al-Azhar University
Ovarian Hyperstimulation Syndrome, Infertility, Female
Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome
The present study aims to evaluate whether the use of a "dual trigger" can improve IVF outcomes, compared to GnRH agonist (GnRH-a) alone, in patients at high risk of OHSS undergoing a freeze-all cycle.
- Trial name
- NCT05638529
- Testing
- Pregnyl (1,500) IU, 1.5 mL of normal saline
- Where
- Canada
- Volunteers
- 80 people
- Sponsor
- Mount Sinai Hospital, Canada